Get the Stockscreener App
7.15
13.85%
0.87
After Hours:
7.01
-0.14
-1.96%
Optimizerx Corp stock is traded at $7.15, with a volume of 2.45M.
It is up +13.85% in the last 24 hours and up +13.67% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$6.28
Open:
$6.33
24h Volume:
2.45M
Relative Volume:
5.11
Market Cap:
$131.94M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-8.9375
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+51.48%
1M Performance:
+13.67%
6M Performance:
-8.33%
1Y Performance:
-47.15%
1-Day Range:
$6.2018
$7.83
1-Week Range:
$3.9914
$7.83
52-Week Range:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
7.15 | 131.94M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
OptimizeRx (NASDAQ:OPRX) Issues Quarterly Earnings Results - MarketBeat
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OptimizeRx receives board nomination notice from Whetstone By Investing.com - Investing.com Australia
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations - The Manila Times
OPTIMIZERx receives director nominations from Whetstone Capital Advisors -March 11, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx receives board nomination notice from Whetstone - Investing.com
OptimizeRx Faces Board Shakeup as Activist Investor Pushes for Change - StockTitan
OptimizeRx appoints Steve Silvestro as new CEO By Investing.com - Investing.com Australia
OptimizeRx appoints Steve Silvestro as new CEO - Investing.com India
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer - The Manila Times
OPTIMIZERx appoints Stephen Silvestro as CEO -March 10, 2025 at 07:42 am EDT - Marketscreener.com
OptimizeRx Promotes CCO Steve Silvestro to Chief Executive Officer - StockTitan
OptimizeRx (OPRX) to Release Earnings on Wednesday - MarketBeat
OptimizeRx Corp. to Host Earnings Call - ACCESS Newswire
What Does OptimizeRx Corporation's (NASDAQ:OPRX) Share Price Indicate? - Yahoo Finance
Investor Network: OptimizeRx Corp to Host Earnings Call - ACCESS Newswire
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET - The Manila Times
OptimizeRx Corp. Announces Conference Call to Discuss Fiscal 2024 Financial Results on March 12, 2025 - Nasdaq
OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March ... - The Bakersfield Californian
OptimizeRx Co. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Head to Head Review: NextMart (OTCMKTS:NXMR) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles - Investing.com
SG Americas Securities LLC Acquires New Stake in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Why Insider Buys at OptimizeRx Could Signal Undervalued Potential - Smartphone Magazine
One OptimizeRx Insider Raised Their Stake In The Previous Year - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Receives "Market Outperform" Rating from JMP Securities - MarketBeat
JPMorgan Chase & Co. Sells 104,750 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Where OptimizeRx Stands With AnalystsOptimizeRx (NASDAQ:OPRX) - Benzinga
Whetstone Capital Discloses 8.2% Stake in OptimizeRx, Urges Strategic Alternatives - Yahoo Finance
OptimizeRx Co. (NASDAQ:OPRX) Receives $9.06 Consensus Target Price from Brokerages - Defense World
Chuck Royce's Strategic Acquisition of OptimizeRx Corp Shares - GuruFocus.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx (NASDAQ:OPRX) adds US$12m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Strong week for OptimizeRx (NASDAQ:OPRX) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Contrasting Ucommune International (NASDAQ:UK) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Jane Street Group LLC - Defense World
OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook - MSN
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):